Roble Belko & Company’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.18M Buy
104,751
+48,220
+85% +$1.01M 0.24% 46
2026
Q1
$1.18M Buy
56,531
+35,539
+169% +$751K 0.15% 55
2025
Q4
$444K Hold
20,992
– – 0.06% 87
2025
Q3
$445K Hold
20,992
– – 0.06% 79
2025
Q2
$442K Hold
20,992
– – 0.06% 80
2025
Q1
$436K Buy
20,992
+1,127
+6% +$23.1K 0.07% 80
2024
Q4
$404K Buy
19,865
+4,870
+32% +$101K 0.06% 82
2024
Q3
$318K Buy
14,995
+1,874
+14% +$39.1K 0.05% 86
2024
Q2
$266K Buy
13,121
+2,860
+28% +$57.7K 0.04% 93
2024
Q1
$210K Buy
10,261
+2,821
+38% +$57.7K 0.04% 99
2023
Q4
$155K Buy
+7,440
New +$147K 0.03% 99

Other funds holding IBDW

Roble Belko & Company's IBDW Position: Q2 2026 in Review

Roble Belko & Company increased its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 85% in Q2 2026, buying an estimated $1.01M and bringing the position to 104,751 shares worth $2.18M. The position accounts for 0.24% of the portfolio, ranked #46.

Roble Belko & Company first reported a position in IBDW in Q4 2023 and has held it in 11 quarters since. 291 funds tracked by Wall St. Rank hold IBDW as of Q2 2026.

  • Roble Belko & Company held 104,751 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $2.18M as of Q2 2026.
  • Roble Belko & Company bought 48,220 iShares iBonds Dec 2031 Term Corporate ETF shares in Q2 2026, an estimated $1.01M.
  • iShares iBonds Dec 2031 Term Corporate ETF made up 0.24% of Roble Belko & Company's portfolio in Q2 2026, its #46 holding.
  • Roble Belko & Company first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q4 2023 and has held it in 11 quarters since.
  • 291 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q2 2026.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.